Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cancer patients face double danger: clots and bleeding studied

NCT ID NCT03826043

First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 31 times

Summary

This study looked at how often cancer patients who are also at risk for bleeding develop dangerous blood clots. Researchers followed 700 hospitalized cancer patients to track clot rates and understand how to better manage these situations. The goal was to gather information to improve future care, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centre Antoine Lacassagne

    Nice, 06189, France

Conditions

The condition(s) this trial relates to.

neoplasm thrombotic disease vascular hemostatic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.